280 262 Part II Advanced Topics 5. Was a sensitivity analysis conducted? If so, on what variables? References 1. Bootman JL, Townsend RJ, McGhan WF. Introduction to pharmacoeconomics. In Bootman JL, Townsend RJ, McGhan WF (eds). Principles of Pharmacoeconomics (3rd ed.). Cincinnati, OH: Harvey Whitney Books Co, National Center for Health Services Research and Development. Report of the Task Force on the Pharmacist's Clinical Role. Journal of the American Pharmaceutical Association 11(9): , Bootman LJ, Wertheimer AI, Zaske D, Rowland C. Individualizing gentamicin dosage in burn patients with gram-negative septicemia: A cost-benefit approach. Journal of the Pharmaceutical Sciences 68(3): , Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. American Journal of Hospital Pharmacy 47(3): , Centers for Medicare & Medicaid Services. Medication therapy management and quality improvement program. In Medicare Prescription Drug Benefit Manual. Available at cms.hhs.gov/prescriptiondrugcovcontra/downloads/pdbmanual_chapter7.pdf; accessed January Blumenschein K, Johannesson M. Use of contingent valuation to place a monetary value on pharmacy services: An overview and review of the literature. Clinical Therapeutics 21(8): , Suh DC. Consumers willingness-to-pay for pharmacy services that reduce risk of medicationrelated problems. Journal of the American Pharmacists Association 40(6): , Rupp MT. Value of community pharmacists interventions to correct prescribing errors. Annals of Pharmacotherapy 26(12): , Dobie RL, Rascati KL. Documenting the value of pharmacist interventions. American Pharmacy NS34(5):50 54, Lee AJ, Boro MS, Knapp KK, et al. Clinical and economics outcomes of pharmacist recommendations in a Veterans Affairs Medical Center. American Journal of Health-System Pharmacy 59(2): , Willett MS, Bertch KE, Rich DS, et al. Prospectus on the economic value of clinical pharmacy services. Pharmacotherapy 9(1):45 56, Schumock GT, Meek PD, Ploetz PA, Vermeulen LC. Economic evaluations of clinical pharmacy services: Pharmacotherapy 16(6): , Schumock GT, Butler MG, Meek PD, et al. Evidence of the economic benefit of clinical pharmacy services: Pharmacotherapy 23(1): , Posey LM. Proving that pharmaceutical care makes a difference in community pharmacy. Journal of the American Pharmacist Association 43(2): , Carter BL, Malone DC, Billups SJ, et al. Interpreting the findings of the IMPROVE study. American Journal of Health-System Pharmacy 58(14): , Cranor CW, Bunting BA, Christensen DB. The Asheville Project: Long-term clinical and economic outcomes of a community pharmacy diabetes care program. Journal of the American Pharmacist Association 43(2): , Bunting BA, Cranor CW. The Asheville Project: Long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma. Journal of the American Pharmacists Association 46(2): , 2006.
essentials of pharmacoeconomics karen rascati pdf download
2ff7e9595c
Comments